Perspective

Tangent90 Appoints Gemma Cholerton As Marketing Director

London, United Kingdom – 3rd August 2021: Tangent90 Ltd, a leading technology company developing innovative solutions that enable pharma to overcome the challenges of sharing scientific digital content with healthcare professionals (HCPs), welcome the appointment of Gemma Cholerton as Marketing Director. 

Gemma joins from global pharmaceutical regulatory solutions provider, PharmaLex, where she held a senior marketing role, leading the marketing strategy for online and digital, brand implementation and PR. In moving to Tangent90, Gemma saw an opportunity to help the company formalise its marketing activities and support its ambitious growth plans.  

“It is an exciting opportunity to join a company that is seeing significant growth, despite the challenges of the last 18 months”, explained Gemma. “Tangent90 are ahead of the curve when it comes to digital engagement through copyright scientific content and with the momentum shifting in pharma to drive the adoption of digital solutions, there’s a real opportunity to showcase what we can do”, she added. 

“As a growing company, we recognised the need to add structure to our marketing efforts”, explained Jan van den Burg, CEO at Tangent90. “Gemma’s experience is a clear advantage and will enable us to optimise the opportunity to support pharma in taking their digital communications to the next level”, he added.  

>> Download Full Article

Related news

Medical journal

Why relevance and impact are so important for HCPs

Making an impact attracts attention. Doesn’t it? Well, yes but only if the subject of the impact is relevant to the person being impacted. For it to resonate, it needs to be timed to perfection and the subject be of specific relevance to the recipient.

T90 Perspective

The omnichannel revolution

Omnichannel is more than just a buzzword. It is influencing the customer journey in pharma. Adding published scientific content to your omnichannel strategy can help add greater value for HCPs. Read the T90 perspective>>

Personalised email

Making it personal

What would make you more likely to respond? A dry, generic, mass-produced approach or one that addresses you personally and provides specific information on a topic of interest in an easy-to-digest format via a channel of your choice? We know what we’d prefer!

Scroll to Top

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.